DPP4 and T-cell acute lymphoblastic leukemia: CD26/DPP4 is expressed on aggressive T-cell hematological malignancies such as T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL) and was associated with poor survival [108].